Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab Research Letter

  

Authors:	Parisi, R.; Cowen, E. A.; Gu, S.; Dusza, S.; Pulitzer, M.; Geyer, M. B.; King, A. C.; Markova, A.
Title:	Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab
Keywords:	adult; clinical article; middle aged; antibiotic agent; monotherapy; antineoplastic agents; cancer patient; neurotoxicity; antineoplastic agent; letter; t lymphocyte; t-lymphocytes; multiple cycle treatment; retrospective study; psoriasis; acute lymphoblastic leukemia; rash; minimal residual disease; lymphoma, non-hodgkin; acne; panniculitis; precursor cell lymphoblastic leukemia-lymphoma; emollient agent; skin disease; dermatitis; hydrocortisone; adverse drug reaction; non-hodgkin lymphoma; triamcinolone; contact dermatitis; cytokine release syndrome; nail dystrophy; folliculitis; antibodies, bispecific; seborrheic dermatitis; bispecific antibody; blinatumomab; eczema; humans; human; male; female; face erythema; immune effector cell associated neurotoxicity syndrome; precursor b-cell lymphoblastic leukemia-lymphoma; desoximetasone; papular skin disease
Journal Title:	Leukemia and Lymphoma
Volume:	64
Issue:	9
ISSN:	1042-8194
Publisher:	Taylor & Francis Group
Date Published:	2023-01-01
Start Page:	1583
End Page:	1587
Language:	English
DOI:	10.1080/10428194.2023.2221756
PUBMED:	37309201
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85161815845&doi=10.1080%2f10428194.2023.2221756&partnerID=40&md5=e081ff6e1c839d6ec0b2c2e2fadc4bfd
Notes:	Letter -- MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PubMed and PDF -- MSK corresponding author is Alina Markova -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/210050